Sensei Biotherapeutics Q2 2024 GAAP EPS $(0.28) Misses $(0.27) Estimate
Portfolio Pulse from Benzinga Newsdesk
Sensei Biotherapeutics reported a Q2 2024 GAAP EPS of $(0.28), missing the estimate of $(0.27).
August 06, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sensei Biotherapeutics reported a Q2 2024 GAAP EPS of $(0.28), missing the estimate of $(0.27). This slight miss may lead to a negative short-term impact on the stock price.
The reported EPS of $(0.28) is slightly below the estimated $(0.27). Even though the miss is minor, it could still lead to a negative short-term reaction from investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100